Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

Incyte (INCY) “announced that the FDA has approved Opzelura cream 1.5%, a topical Janus kinase inhibitor, for the short-term and non-continuous ...

If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent “Breakthrough ...

Rosacea can cause redness, breakouts, and discomfort. Here, dermatologists share moisturizers that may help color-correct ...

Adults who suffer from the common disorder are significantly more likely to express suicidal thoughts, concerning new ...

Doctors have shared their top tips for travelling with eczema, offering some wise words for people who find heading to ...

U.S. Dermocosmetics Market Forecast to Reach USD 10.71 Billion by 2032, Growing at a 7.67% CAGR.Austin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Dermocosmetics Market Size Analysis: According to S&S Insider ...

Summer brings long days, outdoor fun, and plenty of sunshine—but for people living with chronic skin conditions like eczema, ...

Childhood allergies can lead to symptoms ranging from sneezing to life-threatening anaphylaxis. Understanding causes, early ...

Dry skin around the nose, a common issue worsened by environmental factors and skin conditions, can be effectively managed ...